4.6 Article

Cerebrospinal fluid A levels correlate with structural brain changes in Parkinson's disease

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Clinical Neurology

An evaluation of the impact of MAPT, SNCA and APOE on the burden of Alzheimer's and Lewy body pathology

Christian Wider et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2012)

Article Geriatrics & Gerontology

Hippocampal and ventricular changes in Parkinson's disease mild cognitive impairment

Liana Apostolova et al.

NEUROBIOLOGY OF AGING (2012)

Article Clinical Neurology

CSF amyloid β38 as a novel diagnostic marker for dementia with Lewy bodies

Ezra Mulugeta et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2011)

Review Clinical Neurology

White matter lesions in Parkinson disease

Nicolaas I. Bohnen et al.

NATURE REVIEWS NEUROLOGY (2011)

Article Clinical Neurology

The progression of pathology in Parkinson's disease

Glenda Margaret Halliday et al.

YEAR IN NEUROLOGY 2 (2010)

Article Neurosciences

Brain Atrophy in Healthy Aging Is Related to CSF Levels of Aβ1-42

Anders M. Fjell et al.

CEREBRAL CORTEX (2010)

Article Clinical Neurology

The age-related white matter changes scale correlates with cognitive impairment

Y. Xiong et al.

EUROPEAN JOURNAL OF NEUROLOGY (2010)

Article Clinical Neurology

CSF amyloid-β and tau proteins, and cognitive performance, in early and untreated Parkinson's Disease: the Norwegian ParkWest study

Guido Alves et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2010)

Article Clinical Neurology

CSF Aβ42 and tau in Parkinson's Disease with Cognitive Impairment

Thomas J. Montine et al.

MOVEMENT DISORDERS (2010)

Article Geriatrics & Gerontology

Ventricular maps in 804 ADNI subjects: correlations with CSF biomarkers and clinical decline

Yi-Yu Chou et al.

NEUROBIOLOGY OF AGING (2010)

Article Geriatrics & Gerontology

3D PIB and CSF biomarker associations with hippocampal atrophy in ADNI subjects

Liana G. Apostolova et al.

NEUROBIOLOGY OF AGING (2010)

Article Clinical Neurology

In vivo amyloid imaging in autopsy-confirmed Parkinson disease with dementia

M. A. Burack et al.

NEUROLOGY (2010)

Article Clinical Neurology

CSF amyloid β 1-42 predicts cognitive decline in Parkinson disease

A. Siderowf et al.

NEUROLOGY (2010)

Article Neurosciences

Effects of cerebrovascular disease on amyloid precursor protein metabolites in cerebrospinal fluid

Per Selnes et al.

FLUIDS AND BARRIERS OF THE CNS (2010)

Article Medicine, General & Internal

CSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment

Niklas Mattsson et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)

Article Geriatrics & Gerontology

APOE Alleles in Parkinson Disease and Their Relationship to Cognitive Decline: A Population-based, Longitudinal Study

Martin Wilhelm Kurz et al.

JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY (2009)

Article Clinical Neurology

Incidence of Parkinson's disease in Norway: the Norwegian ParkWest study

G. Alves et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2009)

Review Clinical Neurology

Neurochemical Biomarkers in the Differential Diagnosis of Movement Disorders

Brit Mollenhauer et al.

MOVEMENT DISORDERS (2009)

Article Clinical Neurology

Trajectories of brain loss in aging and the development of cognitive impairment

N. E. Carlson et al.

NEUROLOGY (2008)

Article Clinical Neurology

Subtypes of mild cognitive impairment in Parkinson's disease: Progression to dementia

Carmen Cristea Janvin et al.

MOVEMENT DISORDERS (2006)

Review Medicine, General & Internal

Alzheimer's disease

Kaj Blennow et al.

LANCET (2006)

Article Clinical Neurology

Visual rating of white matter hyperintensities in Parkinson's disease

MK Beyer et al.

MOVEMENT DISORDERS (2006)

Article Clinical Neurology

Cognitive profile of patients with newly diagnosed Parkinson disease

D Muslimovic et al.

NEUROLOGY (2005)

Article Neurosciences

Mapping hippocampal and ventricular change in Alzheimer disease

PM Thompson et al.

NEUROIMAGE (2004)